← All Posts
UTH
United Therapeutics Corporation
June 27, 2026
•
Author: Phil Ratcliff
•
UTHR
| Item |
Proposal |
Vote |
| 1 |
Election of Directors |
|
| 1a |
Christopher Causey |
✓ For(60.317)
|
| 1b |
Richard Giltner |
✓ For(60.317)
|
| 1c |
Ray Kurzweil |
✓ For(60.317)
|
| 1d |
Jan Malcolm |
✓ For(60.317)
|
| 1e |
Linda Maxwell |
✓ For(60.317)
|
| 1f |
Nilda Mesa |
✓ For(60.317)
|
| 1g |
Judy Olian |
✓ For(60.317)
|
| 1h |
Christopher Patusky |
✓ For(60.317)
|
| 1i |
Martine Rothblatt |
✗ Against(60.317)
|
| 1j |
Louis Sullivan |
✓ For(60.317)
|
| 1k |
Tommy Thompson |
✓ For(60.317)
|
| 1l |
Kevin Tracey |
✓ For(60.317)
|
| 2 |
Advisory resolution to approve executive compensation |
✓ For(60.317)
|
| 3 |
Approval of the United Therapeutics Corporation 2026 Stock Incentive Plan |
✓ For(60.317)
|
| 4 |
Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026 |
✓ For(60.317)
|
This article was written for information purposes only and its content should not be
construed by any consumer and/or prospective client as rebel Financial's solicitation
to affect, or attempt to affect transactions in securities, or the rendering of
personalized investment advice for compensation. No client or prospective client should
assume that any such discussion serves as the receipt of, or a substitute for,
personalized advice from rebel Financial, or from any other investment professional.
See our disclosures page for more information.
rebel Financial